API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
0
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
1. Ac 0137
2. Ac 137
3. Lys-cys-asn-thr-ala-thr-cys-ala-thr-gln-arg-leu-ala-asn-phe-leu-val-his-ser-ser-asn-asn-phe-gly-pro-ile-leu-pro-pro-thr-asn-val-gly-ser-asn-thr-tyr-nh2
4. Pramlintide
5. Pramlintide Acetate
6. Tripro-amylin
1. Pramlintide Acetate [usan]
2. Schembl238214
3. Unii-726i6te06g
4. Aco137
5. 726i6te06g
6. 25-l-proline-28-l-proline-29-l-proline-, Acetate (salt), Hydrate
7. 25-l-proline-28-l-proline-29-l-prolineamylin (human) Acetate (salt), Hydrate
Molecular Weight | 3951 g/mol |
---|---|
Molecular Formula | C171H269N51O53S2 |
XLogP3 | -16.7 |
Hydrogen Bond Donor Count | 58 |
Hydrogen Bond Acceptor Count | 59 |
Rotatable Bond Count | 122 |
Exact Mass | 3949.9396798 g/mol |
Monoisotopic Mass | 3948.9363250 g/mol |
Topological Polar Surface Area | 1690 Ų |
Heavy Atom Count | 277 |
Formal Charge | 0 |
Complexity | 9620 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 41 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 2 | |
---|---|
Drug Name | Symlin |
PubMed Health | Pramlintide (Injection) |
Drug Classes | Antidiabetic |
Active Ingredient | Pramlintide acetate |
Dosage Form | Injectable |
Route | Subcutaneous |
Strength | eq 1.5mg base/1.5ml (eq 1mg base/ml); eq 2.7mg base/2.7ml (eq 1mg base/ml) |
Market Status | Prescription |
Company | Astrazeneca Ab |
2 of 2 | |
---|---|
Drug Name | Symlin |
PubMed Health | Pramlintide (Injection) |
Drug Classes | Antidiabetic |
Active Ingredient | Pramlintide acetate |
Dosage Form | Injectable |
Route | Subcutaneous |
Strength | eq 1.5mg base/1.5ml (eq 1mg base/ml); eq 2.7mg base/2.7ml (eq 1mg base/ml) |
Market Status | Prescription |
Company | Astrazeneca Ab |
Hypoglycemic Agents
Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)